ethinyl estradiol has been researched along with dienogest in 43 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (2.33) | 18.7374 |
1990's | 8 (18.60) | 18.2507 |
2000's | 14 (32.56) | 29.6817 |
2010's | 18 (41.86) | 24.3611 |
2020's | 2 (4.65) | 2.80 |
Authors | Studies |
---|---|
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Boer, J; Carol, W; Klinger, G; Michels, W; Pocha, C | 1 |
Balogh, A; Hoffmann, A; Klinger, G; Liewald, S; Liewald, T; Schröder, S; Splinter, FC | 1 |
Carol, W; Jäger, R; Martin, P; Möller, U | 1 |
Feichtinger, W; Gräser, T; Kindermann, C; Mellinger, U; Moore, C; Schneider, B; Spona, J; Walter, F | 1 |
Feichtinger, W; Gräser, T; Kindermann, C; Mellinger, U; Moore, C; Spona, J; Walter, F | 1 |
Carol, W; Gräser, T; Klinger, G; Mellinger, U; Moore, C; Oettel, M; Schindler, AE; Winkler, UH | 1 |
Eick, S; Gräser, T; Klinger, G; Moore, C; Oettel, M; Pfister, W | 1 |
Foster, RH; Wilde, MI | 1 |
Dietrich, H; Hoffmann, H; Wisser, KH; Zimmermann, T | 1 |
Balogh, A; Gräser, G; Kauf, E; Klinger, G; Oettel, M; Vollanth, R | 1 |
Gräser, T; Lippert, TH; Mueck, AO; Oettel, M; Seeger, H | 1 |
Bauer, HH; Gross, W; Kuhl, H; Kutschera, E; Lee, JH; Mellinger, U; Moore, C; von Hayn, C; Wiegratz, I; Winkler, UH | 1 |
Kuhl, H; Kutschera, E; Lee, JH; Mellinger, U; Moore, C; Wiegratz, I; Winkler, UH | 2 |
Domhardt, R; Golbs, S; Kałuzny, Z; Radowicky, S; Wisser, KH; Zimmermann, T | 1 |
Breckwoldt, M | 1 |
Borakowska, B; Radowicki, S; Skórzewska, K | 1 |
Mueck, AO; Seeger, H; Wallwiener, D | 1 |
Kuhl, H; Kutschera, E; Lee, JH; Wiegratz, I; Winkler, UH | 1 |
Dietrich, H; Kuhl, H; Mittmann, K; Wiegratz, I; Zimmermann, T | 1 |
Kuhl, H; Lange, E; Manthey, T; Mellinger, U; Mittmann, K; Sänger, N; Stahlberg, S; Wiegratz, I | 2 |
Gräser, T; Palombo-Kinne, E; Schellschmidt, I; Schumacher, U | 1 |
Kuhl, H; Lange, E; Manthey, T; Mellinger, U; Mittmann, K; Palombo-Kinne, E; Sänger, N; Stahlberg, S; Wiegratz, I | 3 |
Alsina, JC | 1 |
Pérez-Campos, EF | 1 |
Assmann, A; Dinger, J; Minh, TD; Möhner, S | 1 |
Iwen, A; Lehnert, H | 1 |
Duijkers, I; Junge, W; Klipping, C; Mellinger, U; Parke, S; Serrani, M | 1 |
Helmerhorst, FM; Lopez, LM; Raps, M; Van Vliet, HA | 1 |
Macìas, G; Mellinger, U; Merki-Feld, GS; Parke, S; Serrani, M | 1 |
Bitzer, J; Davis, SR; Giraldi, A; Mellinger, U; Nappi, RE; Palacios, S; Parke, S; Serrani, M | 1 |
Bannemerschult, R; Endrikat, J; Gerlinger, C; Marr, J; Mellinger, U; Merz, M; Schellschmidt, I; Trussell, J | 1 |
Cagnacci, A; Grandi, G; Piacenti, I; Volpe, A | 1 |
Nelson, AL | 1 |
Caruso, S; Casella, E; Cianci, A; Cianci, S; Fava, V; Iraci, M | 1 |
Cagnacci, A; Grandi, G; Napolitano, A | 1 |
de la Viuda, E; Lete, I; Martínez, MÁ; Novalbos, J; Pérez-Campos, E; Sánchez-Borrego, R; Sanchez-de la Rosa, R | 1 |
Angioni, S; Cela, V; Litta, P; Luisi, S; Malune, ME; Nappi, L; Pontis, A; Vignali, M | 1 |
Arffman, RK; Haverinen, A; Heikinheimo, O; Hiltunen, JK; Kangasniemi, MH; Komsi, EK; Luiro, K; Piltonen, TT; Tapanainen, JS | 1 |
5 review(s) available for ethinyl estradiol and dienogest
Article | Year |
---|---|
Dienogest.
Topics: Androgen Antagonists; Animals; Clinical Trials as Topic; Contraceptives, Oral; Ethinyl Estradiol; Female; Humans; Nandrolone; Progestins | 1998 |
Ethinylestradiol/dienogest in oral contraception.
Topics: Animals; Contraceptives, Oral, Combined; Ethinyl Estradiol; Female; Humans; Menstrual Cycle; Nandrolone | 2010 |
Quadriphasic versus monophasic oral contraceptives for contraception.
Topics: Contraceptives, Oral, Combined; Estradiol; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Medication Adherence; Menstruation; Nandrolone; Randomized Controlled Trials as Topic; Uterine Hemorrhage | 2011 |
An update on new orally administered contraceptives for women.
Topics: Clinical Trials as Topic; Contraceptives, Oral; Estradiol; Estrogens; Ethinyl Estradiol; Female; Humans; Megestrol; Nandrolone; Norpregnadienes; Progestins | 2015 |
Metabolic impact of combined hormonal contraceptives containing estradiol.
Topics: Blood Pressure; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Estradiol; Ethinyl Estradiol; Hemostasis; Humans; Lipid Metabolism; Megestrol; Nandrolone; Norpregnadienes | 2016 |
24 trial(s) available for ethinyl estradiol and dienogest
Article | Year |
---|---|
Double-blind, randomized, placebo controlled study on the effects of the monophasic oral contraceptive containing 30 micrograms ethinyl estradiol and 2.00 mg dienogest on the hemostatic system.
Topics: Adult; Antithrombin III; Blood Coagulation; Contraceptives, Oral; Double-Blind Method; Ethinyl Estradiol; Factor VII; Female; Fibrin; Fibrinogen; Fibrinolysis; Hemostasis; Humans; Nandrolone; Peptide Fragments; Placebos; Plasminogen; Protein C; Prothrombin; Tissue Plasminogen Activator | 1997 |
Modulation of ovarian function by an oral contraceptive containing 30 micrograms ethinyl estradiol in combination with 2.00 mg dienogest.
Topics: Adult; Contraceptives, Oral; Endometrium; Estradiol; Ethinyl Estradiol; Female; Follicle Stimulating Hormone; Humans; Luteinizing Hormone; Nandrolone; Ovarian Follicle; Ovulation; Progesterone; Ultrasonography | 1997 |
[Effect of ethinyl estradiol-dienogest combination on serum androgen concentrations].
Topics: Adolescent; Adult; Androgen Antagonists; Androgens; Contraceptives, Oral, Combined; Dose-Response Relationship, Drug; Ethinyl Estradiol; Female; Gonadal Steroid Hormones; Humans; Nandrolone; Sex Hormone-Binding Globulin | 1997 |
Influence of hormonal contraceptives on microbial flora of gingival sulcus.
Topics: Adult; Aggregatibacter actinomycetemcomitans; Contraceptives, Oral, Hormonal; Desogestrel; Ethinyl Estradiol; Female; Gingiva; Humans; Nandrolone; Porphyromonas gingivalis; Prevotella intermedia | 1998 |
Effects of two oral contraceptives on plasma levels of insulin-like growth factor I (IGF-I) and growth hormone (hGH).
Topics: Contraceptive Agents, Female; Contraceptives, Oral, Combined; Ethinyl Estradiol; Female; Human Growth Hormone; Humans; Insulin-Like Growth Factor Binding Protein 3; Insulin-Like Growth Factor I; Levonorgestrel; Linear Models; Nandrolone; Time Factors | 2000 |
Effect of dienogest-containing oral contraceptives on lipid metabolism.
Topics: Adolescent; Adult; Contraceptives, Oral, Combined; Double-Blind Method; Estradiol; Estrogens, Conjugated (USP); Ethinyl Estradiol; Female; Humans; Levonorgestrel; Lipids; Nandrolone; Statistics, Nonparametric | 2002 |
Effect of four different oral contraceptives on various sex hormones and serum-binding globulins.
Topics: Adolescent; Adult; Contraceptives, Oral; Dehydroepiandrosterone Sulfate; Double-Blind Method; Estradiol; Ethinyl Estradiol; Female; Gonadal Steroid Hormones; Humans; Levonorgestrel; Nandrolone; Reference Values; Sex Hormone-Binding Globulin; Testosterone; Thyroxine-Binding Proteins; Treatment Outcome | 2003 |
Clinical findings with the oral contraceptive combination ethinylestradiol/dienogest in Poland.
Topics: Acne Vulgaris; Adult; Contraceptives, Oral, Combined; Ethinyl Estradiol; Female; Hair; Humans; Nandrolone; Prospective Studies; Skin | 2002 |
Effect of four oral contraceptives on thyroid hormones, adrenal and blood pressure parameters.
Topics: Adolescent; Adult; Aldosterone; Angiotensin II; Contraceptives, Oral, Combined; Double-Blind Method; Drug Administration Schedule; Endothelin-1; Estradiol; Ethinyl Estradiol; Female; Humans; Hydrocortisone; Levonorgestrel; Nandrolone; Thyroid Hormones; Treatment Outcome | 2003 |
[Influence of a new monophasic oral contraceptive on body metabolism].
Topics: Adolescent; Adult; Basal Metabolism; Cohort Studies; Contraception Behavior; Contraceptives, Oral, Combined; Contraceptives, Oral, Synthetic; Dose-Response Relationship, Drug; Ethinyl Estradiol; Evaluation Studies as Topic; Female; Humans; Nandrolone; Time Factors; Treatment Outcome | 2003 |
Effect of four oral contraceptives on hemostatic parameters.
Topics: alpha-2-Antiplasmin; Antithrombins; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Double-Blind Method; Estradiol; Ethinyl Estradiol; Factor VII; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Fibrinolysin; Homeostasis; Humans; Levonorgestrel; Nandrolone; Peptide Fragments; Plasminogen; Plasminogen Inactivators; Protein C; Prothrombin; Tissue Plasminogen Activator | 2004 |
Fertility after discontinuation of treatment with an oral contraceptive containing 30 microg of ethinyl estradiol and 2 mg of dienogest.
Topics: Adult; Age Distribution; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Estrogens; Ethinyl Estradiol; Female; Fertility; Germany; Humans; Nandrolone; Outcome Assessment, Health Care; Pregnancy; Pregnancy Rate; Risk Assessment; Risk Factors; Treatment Outcome; Withholding Treatment | 2006 |
Effects of an oral contraceptive containing 30 mcg ethinyl estradiol and 2 mg dienogest on thyroid hormones and androgen parameters: conventional vs. extended-cycle use.
Topics: Adult; Androgens; Contraceptives, Oral, Combined; Drug Administration Schedule; Estrogens; Ethinyl Estradiol; Female; Humans; Nandrolone; Prospective Studies; Sex Hormone-Binding Globulin; Testosterone; Thyroid Hormones; Thyroxine-Binding Proteins | 2008 |
Effects of conventional or extended-cycle regimen of an oral contraceptive containing 30 mcg ethinylestradiol and 2 mg dienogest on various hemostasis parameters.
Topics: Adolescent; Adult; Blood Coagulation; Contraceptives, Oral; Contraceptives, Oral, Combined; Estrogens; Ethinyl Estradiol; Female; Germany; Hemostasis; Humans; Nandrolone; Prospective Studies | 2008 |
Efficacy of a combined oral contraceptive containing 0.030 mg ethinylestradiol/2 mg dienogest for the treatment of papulopustular acne in comparison with placebo and 0.035 mg ethinylestradiol/2 mg cyproterone acetate.
Topics: Acne Vulgaris; Adolescent; Adult; Contraceptives, Oral; Cyproterone Acetate; Double-Blind Method; Drug Therapy, Combination; Ethinyl Estradiol; Female; Humans; Middle Aged; Nandrolone; Young Adult | 2009 |
Effects of an oral contraceptive containing 30 mcg ethinyl estradiol and 2 mg dienogest on lipid metabolism during 1 year of conventional or extended-cycle use.
Topics: Adolescent; Adult; Cholesterol; Contraceptives, Oral, Combined; Drug Administration Schedule; Ethinyl Estradiol; Female; Humans; Intention to Treat Analysis; Lipid Metabolism; Nandrolone; Patient Selection; Triglycerides | 2010 |
Effects of combined oral contraceptive ethinylestradiol (30 microg) and dienogest (2 mg) on carbohydrate metabolism during 1 year of conventional or extended-cycle use.
Topics: Adolescent; Adult; Blood Glucose; C-Peptide; Carbohydrate Metabolism; Contraceptives, Oral, Hormonal; Ethinyl Estradiol; Female; Glucose Tolerance Test; Glycated Hemoglobin; Humans; Insulin; Insulin Resistance; Menstruation; Nandrolone; Prospective Studies; Young Adult | 2010 |
Hemostatic effects of a novel estradiol-based oral contraceptive: an open-label, randomized, crossover study of estradiol valerate/dienogest versus ethinylestradiol/levonorgestrel.
Topics: Activated Protein C Resistance; Adolescent; Adult; Antigens; Antithrombin III; Blood Pressure; Contraceptives, Oral, Hormonal; Cross-Over Studies; Drug Combinations; Estradiol; Ethinyl Estradiol; Factor VII; Factor VIII; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Hemostasis; Humans; Levonorgestrel; Middle Aged; Nandrolone; Patient Compliance; Peptide Fragments; Protein C; Protein Precursors; Protein S; Prothrombin; Sex Hormone-Binding Globulin; Young Adult | 2011 |
Effect of extended-cycle regimen with an oral contraceptive containing 30 mcg ethinylestradiol and 2 mg dienogest on bleeding patterns, safety, acceptance and contraceptive efficacy.
Topics: Adult; Contraceptives, Oral; Estrogens; Ethinyl Estradiol; Female; Humans; Menstruation; Nandrolone; Patient Satisfaction; Prospective Studies; Young Adult | 2011 |
Effects of a combined oral contraceptive containing oestradiol valerate/dienogest on hormone withdrawal-associated symptoms: results from the multicentre, randomised, double-blind, active-controlled HARMONY II study.
Topics: Adult; Contraceptives, Oral, Combined; Double-Blind Method; Estradiol; Ethinyl Estradiol; Female; Headache; Humans; Levonorgestrel; Nandrolone; Pelvic Pain; Substance Withdrawal Syndrome; Young Adult | 2013 |
Change to either a nonandrogenic or androgenic progestin-containing oral contraceptive preparation is associated with improved sexual function in women with oral contraceptive-associated sexual dysfunction.
Topics: Adolescent; Adult; Contraceptives, Oral, Combined; Double-Blind Method; Drug Combinations; Drug Substitution; Estradiol; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Middle Aged; Nandrolone; Sexual Dysfunction, Physiological; Young Adult | 2013 |
Different Pearl Indices in studies of hormonal contraceptives in the United States: impact of study population.
Topics: Adult; Androstenes; Cohort Studies; Contraceptive Agents, Female; Contraceptives, Oral, Hormonal; Estradiol; Ethinyl Estradiol; Europe; Female; Humans; Intention to Treat Analysis; Matched-Pair Analysis; Nandrolone; Norpregnenes; Pregnancy; Pregnancy, Unwanted; Progestins; Risk Assessment; South America; Transdermal Patch; United States; Young Adult | 2014 |
Effect on quality of life of switching to combined oral contraception based on natural estrogen: an observational, multicentre, prospective phase IV study (ZOCAL Study).
Topics: Adolescent; Adult; Condoms; Contraceptives, Oral, Combined; Ethinyl Estradiol; Female; Humans; Megestrol; Metrorrhagia; Middle Aged; Nandrolone; Patient Satisfaction; Premenstrual Syndrome; Prospective Studies; Quality of Life; Young Adult | 2016 |
Estradiol Valerate in COC Has More Favorable Inflammatory Profile Than Synthetic Ethinyl Estradiol: A Randomized Trial.
Topics: Adult; C-Reactive Protein; Cholesterol; Contraceptives, Oral, Combined; Estradiol; Ethinyl Estradiol; Female; Humans; Inflammation; Lipid Metabolism; Lipoproteins, LDL; Nandrolone; Serum Amyloid P-Component; Triglycerides; Young Adult | 2020 |
14 other study(ies) available for ethinyl estradiol and dienogest
Article | Year |
---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
[Pharmacokinetics of contraceptive steroids with reference to long-term administration].
Topics: Adolescent; Adult; Contraceptives, Oral, Hormonal; Ethinyl Estradiol; Ethinyl Estradiol-Norgestrel Combination; Female; Humans; Menstrual Cycle; Middle Aged; Nandrolone; Norgestrel; Reference Values | 1991 |
[Effect of a new gestagen--dienogest--and its combination with ethinyl estradiol on the activity of biotransformation reactions].
Topics: Adult; Biotransformation; Caffeine; Contraceptives, Oral; Dipyrone; Estradiol; Ethinyl Estradiol; Female; Humans; Metabolic Clearance Rate; Nandrolone; Progesterone | 1990 |
[The behavior of cytoplasmic progesterone receptors in the cycling endometrium and the effect of hormonal contraceptives].
Topics: Adult; Contraceptives, Oral, Combined; Cytosol; Dose-Response Relationship, Drug; Endometrium; Ethinyl Estradiol; Ethinyl Estradiol-Norgestrel Combination; Female; Humans; Menstrual Cycle; Nandrolone; Norgestrel; Ovulation; Receptors, Progesterone | 1989 |
The efficacy and tolerability of Valette: a postmarketing surveillance study.
Topics: Adolescent; Adult; Contraceptives, Oral, Combined; Dose-Response Relationship, Drug; Estradiol Congeners; Ethinyl Estradiol; Female; Germany; Hormone Antagonists; Humans; Liver; Menstruation; Nandrolone; Pregnancy; Product Surveillance, Postmarketing; Pulmonary Embolism; Thrombosis | 1999 |
The effects of postmenopausal hormone replacement therapy and oral contraceptives on the endogenous estradiol metabolism.
Topics: Adult; Contraceptives, Oral; Estradiol; Estrogen Replacement Therapy; Estrogens, Catechol; Ethinyl Estradiol; Female; Humans; Hydroxyestrones; Middle Aged; Nandrolone; Norethindrone; Norethindrone Acetate; Postmenopause | 2001 |
[Hormone use in migraine].
Topics: Adult; Chronic Disease; Contraceptives, Oral; Estrogens, Conjugated (USP); Ethinyl Estradiol; Female; Humans; Migraine Disorders; Nandrolone; Ovulation Inhibition; Recurrence; Time Factors | 2003 |
Endogenous estradiol metabolism during treatment with oral contraceptives.
Topics: Adult; Contraceptives, Oral, Combined; Estradiol; Ethinyl Estradiol; Female; Humans; Hydroxyestrones; Levonorgestrel; Nandrolone; Norethindrone; Premenopause; Randomized Controlled Trials as Topic | 2004 |
After 50 years of ethinylestradiol, another oestrogen in combined oral contraceptives.
Topics: Contraceptives, Oral, Combined; Ethinyl Estradiol; Female; History, 20th Century; Humans; Nandrolone; Progestins | 2010 |
Risk of venous thromboembolism and the use of dienogest- and drospirenone-containing oral contraceptives: results from a German case-control study.
Topics: Adolescent; Adult; Androstenes; Case-Control Studies; Contraceptives, Oral; Estrogens; Ethinyl Estradiol; Female; Germany; Humans; Levonorgestrel; Logistic Models; Middle Aged; Mineralocorticoid Receptor Antagonists; Nandrolone; Risk Factors; Venous Thromboembolism; Young Adult | 2010 |
[Evaluation of obesity in a 22-year-old female patient].
Topics: Blood Sedimentation; Contraceptives, Oral, Combined; Cushing Syndrome; Dexamethasone; Diagnosis, Differential; Ethinyl Estradiol; Female; Giant Cell Arteritis; Headache; Humans; Hydrocortisone; Nandrolone; Obesity, Morbid; Predictive Value of Tests; Young Adult | 2010 |
Modification of body composition and metabolism during oral contraceptives containing non-androgenic progestins in association with estradiol or ethinyl estradiol.
Topics: Adult; Body Composition; Chlormadinone Acetate; Contraceptives, Oral, Combined; Estradiol; Ethinyl Estradiol; Female; Humans; Metabolism; Nandrolone; Prospective Studies | 2014 |
Comparative, open-label prospective study on the quality of life and sexual function of women affected by endometriosis-associated pelvic pain on 2 mg dienogest/30 µg ethinyl estradiol continuous or 21/7 regimen oral contraceptive.
Topics: Adolescent; Adult; Case-Control Studies; Contraceptives, Oral, Combined; Endometriosis; Estrogens; Ethinyl Estradiol; Female; Follow-Up Studies; Humans; Nandrolone; Pain Measurement; Pelvic Pain; Prognosis; Prospective Studies; Quality of Life; Sexual Behavior; Young Adult | 2016 |
Is dienogest the best medical treatment for ovarian endometriomas? Results of a multicentric case control study.
Topics: Adult; Case-Control Studies; Contraceptives, Oral, Combined; Endometriosis; Ethinyl Estradiol; Female; Hormone Antagonists; Humans; Nandrolone; Ovarian Diseases; Pelvic Pain; Treatment Outcome; Young Adult | 2020 |